Correlation Between Apogee Therapeutics, and Uzabase

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Uzabase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Uzabase into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Uzabase, you can compare the effects of market volatilities on Apogee Therapeutics, and Uzabase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Uzabase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Uzabase.

Diversification Opportunities for Apogee Therapeutics, and Uzabase

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Apogee and Uzabase is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Uzabase in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uzabase and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Uzabase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uzabase has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Uzabase go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Uzabase

If you would invest  4,919  in Apogee Therapeutics, Common on September 12, 2024 and sell it today you would lose (81.00) from holding Apogee Therapeutics, Common or give up 1.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Uzabase

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Uzabase 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Uzabase has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Uzabase is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Apogee Therapeutics, and Uzabase Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Uzabase

The main advantage of trading using opposite Apogee Therapeutics, and Uzabase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Uzabase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uzabase will offset losses from the drop in Uzabase's long position.
The idea behind Apogee Therapeutics, Common and Uzabase pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio